Skip to main content
. 2015 Jun 10;10(2):1123–1130. doi: 10.3892/ol.2015.3349

Table I.

Chemotherapy delivery.

Chemotherapy Number of patients (%)
Neoadjuvant chemotherapy (GEM + NDP)
  Two courses 73 (84.9)
  Three courses 12 (14.0)
  Four courses 1 (1.2)
  25% dose reduction 4 (4.7)
Concurrent chemotherapy (NDP d1-3)
  None 17 (19.8)
  One course 50 (58.1)
  Two courses 19 (22.1)
Adjuvant chemotherapy
  None 26 (30.2)
  One course 40 (46.5)
  Two courses 20 (23.3)

GEM, gemcitabine; NDP, nedaplatin; d, day.